Analysed BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) News Sources
European Equities Traded in the US as American Depositary Receipts Start Week Lower
23-02-2026
yahoo.com
Bicycle Therapeutics (BCYC) Appoints Travis Thompson as CFO Following Leadership Transitions
14-03-2026
yahoo.com
Bicycle Therapeutics (BCYC) Loses 19.0% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
23-03-2026
yahoo.com
After Plunging 20.2% in 4 Weeks, Here's Why the Trend Might Reverse for Bicycle Therapeutics (BCYC)
24-03-2026
yahoo.com
RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11
04-04-2026
yahoo.com
European Equities Traded in the US as American Depositary Receipts Declining in Thursday Trading
16-04-2026
yahoo.com
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
30-07-2026
yahoo.com
Wall Street Analysts Believe Bicycle Therapeutics (BCYC) Could Rally 137.88%: Here's is How to Trade
16-04-2026
yahoo.com
Morgan Stanley Updates Bicycle Therapeutics plc (BCYC) Outlook Amid Pipeline Refocus
17-04-2026
yahoo.com
What is the current price of BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ)?
The current price of BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) is $4.39.
BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) absolute price change since previous trading day?
The absolute price change of BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) since the previous trading day is $0.06.
BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) percentage price change since previous trading day?
The percentage price change of BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) since the previous trading day is 1.3857%.
What is the most recent average sentiment score for BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ)?
The most recent average sentiment score for BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) is 64 out of 100.
What is the most recent average sentiment for BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ)?
The most recent sentiment for BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ) is .
SEC-8K** Filing Available For BICYCLE THERAPEUTICS PLC-ADR (BCYC:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.